Copy to clipboard 
SurGenTec was granted expanded indications for its ION-C Facet Fixation System, allowing for the treatment of cervical pseudoarthrosis when implanted bilaterally within the facet joints. This clearance is supported by long-term clinical evidence from an Institutional Review Board-approved study evaluating long-term surgical outcomes.
ION-C incorporates design features intended to reduce incision size, mitigate intraoperative risk, and preserve native cervical alignment. The system combines a zero-profile implant with a sterile, ready-to-use, single-use instrumentation kit, enabling controlled, non-impact insertion with in-situ depth adjustment.
The ION-C kit includes sterile, single-use disposable instruments and sterile, ready-to-use implants, supporting standardized operating room workflows while reducing reprocessing time, cost, and the risk of infection.
Implant placement is performed using a controlled, non-impact insertion technique that eliminates the need for percussion, minimizing force on the cervical spine and protecting delicate anatomical structures. The ION-C system also enables in-situ implant depth adjustment during and after insertion. A range of implant options supports neutral positioning, specifically designed to preserve native cervical alignment and lordosis. This approach allows fixation without forced distraction or segmental angulation, helping physicians avoid inducing kyphosis during posterior cervical fusion procedures.
“ION-C demonstrates our commitment to delivering cutting-edge solutions that empower physicians with advanced options to treat their patients,” said Travis Greenhalgh, CEO of SurGenTec. “Maintaining native alignment and curvature is critical in spine surgery. ION-C has demonstrated long-term fusion success while preserving the facet joints in a neutral position and minimizing the risk of joint expansion that can lead to postoperative kyphosis.”
Source: SurGenTec
SurGenTec was granted expanded indications for its ION-C Facet Fixation System, allowing for the treatment of cervical pseudoarthrosis when implanted bilaterally within the facet joints. This clearance is supported by long-term clinical evidence from an Institutional Review Board-approved study evaluating long-term surgical outcomes.
ION-C...
SurGenTec was granted expanded indications for its ION-C Facet Fixation System, allowing for the treatment of cervical pseudoarthrosis when implanted bilaterally within the facet joints. This clearance is supported by long-term clinical evidence from an Institutional Review Board-approved study evaluating long-term surgical outcomes.
ION-C incorporates design features intended to reduce incision size, mitigate intraoperative risk, and preserve native cervical alignment. The system combines a zero-profile implant with a sterile, ready-to-use, single-use instrumentation kit, enabling controlled, non-impact insertion with in-situ depth adjustment.
The ION-C kit includes sterile, single-use disposable instruments and sterile, ready-to-use implants, supporting standardized operating room workflows while reducing reprocessing time, cost, and the risk of infection.
Implant placement is performed using a controlled, non-impact insertion technique that eliminates the need for percussion, minimizing force on the cervical spine and protecting delicate anatomical structures. The ION-C system also enables in-situ implant depth adjustment during and after insertion. A range of implant options supports neutral positioning, specifically designed to preserve native cervical alignment and lordosis. This approach allows fixation without forced distraction or segmental angulation, helping physicians avoid inducing kyphosis during posterior cervical fusion procedures.
“ION-C demonstrates our commitment to delivering cutting-edge solutions that empower physicians with advanced options to treat their patients,” said Travis Greenhalgh, CEO of SurGenTec. “Maintaining native alignment and curvature is critical in spine surgery. ION-C has demonstrated long-term fusion success while preserving the facet joints in a neutral position and minimizing the risk of joint expansion that can lead to postoperative kyphosis.”
Source: SurGenTec
You’ve reached your limit.
We’re glad you’re finding value in our content — and we’d love for you to keep going.
Subscribe now for unlimited access to orthopedic business intelligence.
JV
Julie Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.
